Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Share-based Compensation (2022 - 2025)

CervoMed (CRVO) has disclosed Share-based Compensation for 9 consecutive years, with $298735.0 as the latest value for Q4 2025.

  • Quarterly Share-based Compensation fell 11.54% to $298735.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, up 3.05% year-over-year, with the annual reading at $1.4 million for FY2025, 3.05% up from the prior year.
  • Share-based Compensation hit $298735.0 in Q4 2025 for CervoMed, up from $291717.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $578581.0 in Q2 2024 to a low of $62252.0 in Q2 2023.
  • Historically, Share-based Compensation has averaged $248851.3 across 4 years, with a median of $274672.5 in 2022.
  • Biggest five-year swings in Share-based Compensation: crashed 77.62% in 2023 and later soared 829.42% in 2024.
  • Year by year, Share-based Compensation stood at $80988.0 in 2022, then surged by 103.7% to $164972.0 in 2023, then skyrocketed by 104.71% to $337711.0 in 2024, then dropped by 11.54% to $298735.0 in 2025.
  • Business Quant data shows Share-based Compensation for CRVO at $298735.0 in Q4 2025, $291717.0 in Q3 2025, and $497015.0 in Q2 2025.